Esteban-Fernández, Alberto; Calvo-Bernal, Beatriz; López-Vilella, Raquel; de-Lara, Gregorio; Belarte-Tornero, Laia-C; Barrantes-Castillo, Moisés; Gómez-Otero, Inés; Núñez-Villota, Julio; Robles-Gamboa, Carolina; López-Aguilera, José; Torremocha-López, Ana; Melendo-Viu, María; Simón-Ramón, Clara; Fluvia-Burgues, Paula; Pastor-Pérez, Francisco-José; Alonso-Salinas, Gonzalo; García-Pinilla, José-Manuel; Pomares-Varo, Antonia; Gayan-Ordas, Jara; González-Calle, David; Díez-Villanueva, Pablo; Galvan-Ruiz, Mario; Ortiz-Cortes, Carolina; Caravaca-Pérez, Pedro; Goena-Vives, Cristina; Seller, Julia; Jiménez-Blanco, Marta; Codina, Pau; Vietiez, José-María; Jordan-Martínez, Laura; López-Lluva, María-Thiscal; Mena-Sebastia, Elisabet; Pajaro, Pedro; Recio-Mayoral, Alejandro
(OXFORD UNIV PRESS, 2026-05-05)
AIMS: To evaluate the effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction (HFrEF) following recent decompensation in routine clinical practice in Spain. METHODS: VERISEC is ...